{"transactions":[{"id":1170964,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":80752,"kind":"person","name":"D'Andrea Carrie","position":1,"cik":"0001977969","reported_name":"D'Andrea Carrie","relationship":{"officer":true,"officer_title":"VP Clinical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-17T00:58:47.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests quarterly in substantially equal installments over a 3-year period, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.08,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-25-014262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000114036125014262/form4.xml","form_type":"4"}},{"id":1520583,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":80752,"kind":"person","name":"D'Andrea Carrie","position":1,"cik":"0001977969","reported_name":"D'Andrea Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Clinical Operations"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-10T20:11:36.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":19740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment to Form 4 is being filed to amend the signature block in the original Form 4, filed on May 8, 2024, to reflect the correct signatory."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period."}],"balance_after":19740,"derivative":{"exercise_price":2.96,"expiration_date":"2034-05-06","underlying":"Class A Common Shares","underlying_shares":19740},"source":{"system":"sec-edgar","filing":"0000950170-24-057822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000095017024057822/ownership.xml","form_type":"4/A","original_submission_date":"2024-05-08"}},{"id":1523232,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":80752,"kind":"person","name":"D'Andrea Carrie","position":1,"cik":"0001977969","reported_name":"D'Andrea Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Program Management"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-08T23:19:39.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":19740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period."}],"balance_after":19740,"derivative":{"exercise_price":2.96,"expiration_date":"2034-05-06","underlying":"Class A Common Shares","underlying_shares":19740},"source":{"system":"sec-edgar","filing":"0000950170-24-056086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000095017024056086/ownership.xml","form_type":"4"}},{"id":1827756,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":80752,"kind":"person","name":"D'Andrea Carrie","position":1,"cik":"0001977969","reported_name":"D'Andrea Carrie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Clinical Operations"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-18T20:32:53.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months."}],"balance_after":42000,"derivative":{"exercise_price":2.64,"expiration_date":"2033-07-14","underlying":"Class A Common Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001062993-23-014996","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000106299323014996/form4.xml","form_type":"4"}}]}